Dr Frances Rotblat (DHSS) was recorded as having told Cutter that it was extremely rare for the yellow card system for reporting adverse reactions to be used for hepatitis in blood products.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Frances Rotblat